QGEN
$34.25
Qiagen N.V.
($.33)
(.95%)
QGEN
Earnings Whisper ®
N/A
1st Quarter March 2026
Consensus: $0.54
Revenue: $500.40 Mil
Share
Watch
Guidance announcement made Wednesday, February 4, 2026
Latest EPS
Wednesday, February 4, 2026
What do you expect when QGEN reports earnings?
Where is QGEN's stock price going from here?
Analysts
Pivots
Resistance
$36.15
$35.50
$34.87
Support
$33.59
$32.94
$32.31
Description
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.